In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies. 

Life Sciences

Medical Devices

Pharmaceutical

Chugai Pharmabody Research

Hideaki Shimada

Janet Sng

Shervon Lim

Alicia Ang

Zulkarnain H.

Pauline Cheng

Noriyuki Takahashi

Futa Mimoto

Feng Shu

The Leadership Team at Chugai Pharmabody Research drives the strategic vision and operational execution of the company, focusing on advancing innovative antibody drug discovery. This team, comprised of experienced professionals from diverse scientific backgrounds, collaborates to guide research initiatives, foster cross-functional partnerships, and ensure alignment with the company’s mission to address unmet medical needs in the global healthcare landscape.

Leadership Team

Research and Development

Procurement and Purchasing

Leadership Team

About

Team members

Other teams at Chugai Pharmabody Research

Research and Development

Procurement and Purchasing